WB analysis of EGF-treated HEK293T (A), EGF-treated Raw264.7 (B), EGF-treated H9C2 (C) whole cell lysates using GTX55101 PAK2 (phospho Ser20) antibody.
WB analysis of EGF-treated HEK293T (A), EGF-treated Raw264.7 (B), EGF-treated H9C2 (C) whole cell lysates using GTX55101 PAK2 (phospho Ser20) antibody.
PAK2 (phospho Ser20) antibody
GTX55101
ApplicationsWestern Blot
Product group Antibodies
ReactivityHuman, Mouse, Rat
TargetPAK2
Overview
- SupplierGeneTex
- Product NamePAK2 (phospho Ser20) antibody
- Delivery Days Customer9
- Application Supplier NoteWB: 1:500 - 1:1000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsWestern Blot
- CertificationResearch Use Only
- ClonalityPolyclonal
- ConjugateUnconjugated
- Gene ID5062
- Target namePAK2
- Target descriptionp21 (RAC1) activated kinase 2
- Target synonymsgamma-PAK; p21 (CDKN1A)-activated kinase 2; p21 protein (Cdc42/Rac)-activated kinase 2; p21-activated kinase 2; p58; PAK-2; PAK65; PAKgamma; S6/H4 kinase; serine/threonine-protein kinase PAK 2
- HostRabbit
- IsotypeIgG
- Protein IDQ13177
- Protein NameSerine/threonine-protein kinase PAK 2
- Scientific DescriptionThe p21 activated kinases (PAK) are critical effectors that link Rho GTPases to cytoskeleton reorganization and nuclear signaling. The PAK proteins are a family of serine/threonine kinases that serve as targets for the small GTP binding proteins, CDC42 and RAC1, and have been implicated in a wide range of biological activities. The protein encoded by this gene is activated by proteolytic cleavage during caspase-mediated apoptosis, and may play a role in regulating the apoptotic events in the dying cell. [provided by RefSeq, Jul 2008]
- ReactivityHuman, Mouse, Rat
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203
References
- The dynactin subunit DCTN1 controls osteoclastogenesis via the Cdc42/PAK2 pathway. Lee YD et al., 2020 Mar, Exp Mol MedRead more